These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13004570)

  • 1. [Place of hepatic steatosis in the evolution of alcoholic cirrhosis].
    LOISY C; PLAUCHU M; GIRARD M
    Rev Int Hepatol; 1952; 2(4):631-43. PubMed ID: 13004570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histochemical aspects of hepatic steatosis in some liver diseases in dogs. Fate of steatosis in vitro. (Contribution to the biochemical pathogenesis of Laennec type liver cirrhosis in dogs)].
    DI DOMIZIO G
    Biol Lat; 1960; 72():713-66. PubMed ID: 24546335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, biological and histological study of the development of steatosis into alcoholic cirrhosis of the liver].
    ALBOT G; HERMAN J; CORTEVILLE M
    Presse Med (1893); 1953 Apr; 61(28):589-93. PubMed ID: 13074083
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis.
    Meier EM; Pohl R; Rein-Fischboeck L; Schacherer D; Eisinger K; Wiest R; Krautbauer S; Buechler C
    Cytokine; 2016 Sep; 85():45-50. PubMed ID: 27288631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver.
    Thaler H
    Tokai J Exp Clin Med; 1980 Apr; 5(2):233-42. PubMed ID: 7414634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
    Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stellate reticuloendotheliocytes in cirrhosis of the liver].
    Aruin LI; Loginov AS; Shatalova OL
    Arkh Patol; 1987; 49(3):31-7. PubMed ID: 3593004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatosis and portal hypertension.
    Puoti C; Bellis L
    Eur Rev Med Pharmacol Sci; 2005; 9(5):285-90. PubMed ID: 16231591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma fibronectin and alcoholic liver disease].
    Ricciardi R; Restuccia G; Chindemi G
    Quad Sclavo Diagn; 1987 Jun; 23(2):153-63. PubMed ID: 3451292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term prognosis in chronic liver diseases].
    Becker K
    Wien Med Wochenschr; 1980 Sep; 130(17):549-54. PubMed ID: 7006222
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis.
    Takahashi H; Suzuki M; Ikeda H; Kobayashi M; Sase S; Yotsuyanagi H; Maeyama S; Iino S; Itoh F
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S7-S13. PubMed ID: 18986379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alcoholic cirrhosis. Pathological anatomy].
    Bioulac-Sage P; Callard P
    Rev Prat; 1993 Sep; 43(14):1862-6. PubMed ID: 8310235
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laënnec's cirrhosis and their validation by sequential analysis.
    BARTHOLOMAY AF; ROBIN ED; VALLEE RL; WACKER WE
    N Engl J Med; 1956 Aug; 255(9):403-8. PubMed ID: 13358854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Circulating immune complexes in liver diseases (author's transl)].
    Sodomann CP; Prokein K; Schmidt H; Martini GA
    Z Gastroenterol; 1978 Aug; 16(8):501-11. PubMed ID: 685347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic procedures in the evaluation of hepatic diseases. Laparoscopy.
    Henning H
    Lab Res Methods Biol Med; 1983; 7():469-88, C2-8. PubMed ID: 6312229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.